The marine pharmaceuticals market is forecasted to grow by USD 1956.93 mn during 2023-2028, accelerating at a CAGR of 8.63% during the forecast period. The report on the marine pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising consumer demand for natural products, the growing prevalence of chronic diseases, and the presence of rich marine biodiversity.
Technavio's marine pharmaceuticals market is segmented as below:
By Product
Oncology
Cardiovascular
Anti-infectives
Others
By Type
Health supplements
Drugs
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the rise of antibiotics from marine microbes as one of the prime reasons driving the marine pharmaceuticals market growth during the next few years. Also, research for anti-inflammatory compounds from marine sources and the emergence of digitalization and data analytics will lead to sizable demand in the market.
The report on the marine pharmaceuticals market covers the following areas:
Marine pharmaceuticals market sizing
Marine pharmaceuticals market forecast
Marine pharmaceuticals market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading marine pharmaceuticals market vendors that include Abbott Laboratories, BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Croda International Plc, DEKRA SE, EID Parry India Ltd., Eisai Co. Ltd., GFR Pharma, GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Koninklijke DSM NV, MARINE LIFESCIENCES, Merck KGaA, Pfizer Inc., PharmaMar SA, Roquette Freres SA, TerSera Therapeutics LLC, and ZELNOVA ZELTIA S.A.. Also, the marine pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
2.2 Value chain analysis
Exhibit 12: Value Chain Analysis
3 Market Sizing
3.1 Market definition
Exhibit 13: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 14: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global bra market 2018 - 2022
Exhibit 19: Historic Market Size - Data Table on global bra market 2018 - 2022 ($ million)